PapaG Lab is part of newly funded Cancer Grand Challenges InteroCANCEption Team

We are excited to be part of InteroCANCEption, a newly funded Cancer Grand Challenges team tackling how the brain and nervous system sense tumors and shape cancer progression.

In vivo models bring FSP1 inhibitors to life

News and Views by Olzmann lab about our groups recent study on targeting FSP1 to promote ferroptosis in cancer

Dr. Papagiannakopoulos The Scientist webinar about Cell Signaling and Metabolism

Read more

New Study by Papagiannakopoulos Lab determines how antioxidants can promote metastasis

Read more:

Nature.com

ScienceDirect.com

ScienceNews

ScienceDaily.com

DailyMail.co.uk

MedicalNewsToday.com

EurekAlert.org

Papagiannakopoulos Lab awarded NCI MERIT R37 award, 2018-2024

Read more

Keap1 Loss Drives Kras-Mutant Lung Cancer and Glutaminolysis Dependency

Read more

Papagiannakopoulos Lab featured in the Perlmutter Cancer Center 2017 Year in Review

Read more

New Research System Finds & Targets Vulnerabilities in Lung Cancer Cells

Click to read NYU Health news
Click to read MIT news
Click to read Fierce Biotech news

Papagiannakopoulos Lab awarded new grants

- Awarded NIH/NCI first R01 award "Identifying metabolic dependencies in genetic subtypes of KRAS-driven lung cancer”

- Awarded American Cancer Society Research Scholar Grant "Characterizing the role of serine uptake in KRAS-driven lung cancer”

Volkan presents at Fourth Postdoctoral Annual Research Day at NYUMC

Read more

Why working the night shift can pose a cancer risk

Read more
News.MIT.edu
Kathimerini.gr (Greek article)

Volkan Sayin interviewed by Akademiliv

Read the interview

Fast modeling of cancer mutations

Read more

New view of tumors’ evolution

Read more